Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Langer

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Clinical Lung Cancer|August 12, 2011
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancerWaldo Ortuzar, Nasser Hanna, Eduardo Pennella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599Corey Langer, Sigui Li, Joan Schiller, et al.
Clinical Lung Cancer|November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLCMargaret Stalker, Melina Marmarelis, Corey Langer, et al.
Cancer Causes & Control : CCC|April 23, 2013
Is a cancer diagnosis a teachable moment for the patient's relative who smokes?Robert A Schnoll, E Paul Wileyto, Frank T Leone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501)Gregory A Masters, Sigui Li, Afshin Dowlati, et al.
Experimental and Therapeutic Medicine|April 20, 2013
Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neckJessica Bauman, Corey Langer, Harry Quon, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|June 20, 2013
Complementary and alternative medicine use and benefit finding among cancer patientsSheila N Garland, David Valentine, Krupali Desai, et al.
Clinical Lung Cancer|May 10, 2011
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213Elizabeth Gore, Kyounghwa Bae, Corey Langer, et al.
Clinical Lung Cancer|July 7, 2011
Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom controlGeorge Rodrigues, Fergus Macbeth, Bryan Burmeister, et al.
Clinical Lung Cancer|July 6, 2013
Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapiesJoshua Bauml, Rosemarie Mick, Yu Zhang, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Clinical Lung Cancer|August 12, 2011
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancerWaldo Ortuzar, Nasser Hanna, Eduardo Pennella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599Corey Langer, Sigui Li, Joan Schiller, et al.
Clinical Lung Cancer|November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLCMargaret Stalker, Melina Marmarelis, Corey Langer, et al.
Cancer Causes & Control : CCC|April 23, 2013
Is a cancer diagnosis a teachable moment for the patient's relative who smokes?Robert A Schnoll, E Paul Wileyto, Frank T Leone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501)Gregory A Masters, Sigui Li, Afshin Dowlati, et al.
Experimental and Therapeutic Medicine|April 20, 2013
Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neckJessica Bauman, Corey Langer, Harry Quon, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|June 20, 2013
Complementary and alternative medicine use and benefit finding among cancer patientsSheila N Garland, David Valentine, Krupali Desai, et al.
Clinical Lung Cancer|May 10, 2011
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213Elizabeth Gore, Kyounghwa Bae, Corey Langer, et al.
Clinical Lung Cancer|July 7, 2011
Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom controlGeorge Rodrigues, Fergus Macbeth, Bryan Burmeister, et al.
Clinical Lung Cancer|July 6, 2013
Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapiesJoshua Bauml, Rosemarie Mick, Yu Zhang, et al.
Pageof 11